InsituGen is reinventing steroid hormone testing with the world's first low-cost test for the detection of androgen and estrogen bioactivity
InsituGen has raised $297K in total funding. The most recent round was Seed. The last funding was announced in April 2024.
InsituGen's investors include New Zealand Growth Capital Partners, Enterprise Angels, Pacific Channel, Angel Investors Marlborough, Booster.
InsituGen is headquartered in Dunedin, New Zealand.
InsituGen is reinventing steroid hormone testing with the world's first low-cost test for the detection of androgen and estrogen bioactivity
InsituGen is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InsituGen — Funding & Investors." VCBacked, April 28, 2024, https://www.vcbacked.co/company/insitugen. Accessed July 19, 2026.
VCBacked. (2024). InsituGen — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/insitugen
{{cite web |title=InsituGen — Funding & Investors |url=https://www.vcbacked.co/company/insitugen |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated